+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Needle Free Drug Delivery Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4840271
  • Report
  • August 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • 3 M
  • AkraDermojetInc
  • Antares Pharma Inc.
  • Bayer Ag
  • GlaxosmithklinPlc
  • InjexPharma Ag
  • MORE
The report on the global needle free drug delivery devices market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global needle free drug delivery devices market to grow with a CAGR of 6.5% over the forecast period from 2019-2025. The study on needle free drug delivery devices market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on needle free drug delivery devices market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global needle free drug delivery devices market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global needle free drug delivery devices market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • The growing incidences of chronic disease like HIV aids, dengue, and hepatitis
  • Occurrence of well-developed healthcare facilities
2) Restraints
  • High initial costs of needle-free drug delivery devices
3) Opportunities
  • Technological advancements in terms of pain-free drug transportation and self-administration
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global needle free drug delivery devices market is segmented on the basis of technology, and application.

The Global Needle Free Drug Delivery Devices Market by Technology
  • Jet Injectors
  • Inhaler Technology
  • Transdermal Patch Technology
  • Novel Needle-free Technologies
  • Oral Drug Delivery System
The Global Needle Free Drug Delivery Devices Market by Application
  • Vaccine Delivery
  • Pain Management
  • Insulin Delivery For Diabetes
  • Pediatric Injections
  • Other Applications
Company Profiles
The companies covered in the report include
  • 3 M
  • AkraDermojetInc
  • Antares Pharma Inc.
  • Bayer Ag
  • Bioject Medical Technologies, Inc.
  • GlaxosmithklinPlc
  • Glide Pharmaceutical Technologies Ltd.
  • InjexPharma Ag
  • Medtronic, Inc.
  • Zogenix, Inc.
  • Other companies.
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the needle free drug delivery devices market.
2. Complete coverage of all the segments in the needle free drug delivery devices market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global needle free drug delivery devices market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 3 M
  • AkraDermojetInc
  • Antares Pharma Inc.
  • Bayer Ag
  • GlaxosmithklinPlc
  • InjexPharma Ag
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Needle Free Drug Delivery Devices Market Highlights
2.2. Needle Free Drug Delivery Devices Market Projection
2.3. Needle Free Drug Delivery Devices Market Regional Highlights

3. Global Needle Free Drug Delivery Devices Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Technology
3.4.2. Growth Matrix Analysis by Application
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Needle Free Drug Delivery Devices Market

4. Needle Free Drug Delivery Devices Market Macro Indicator Analysis

5. Global Needle Free Drug Delivery Devices Market by Technology
5.1. Jet Injectors
5.2. Inhaler Technology
5.3. Transdermal Patch Technology
5.4. Novel Needle Free Technologies
5.5. Oral Drug Delivery System

6. Global Needle Free Drug Delivery Devices Market by Application
6.1. Vaccine Delivery
6.2. Pain Management
6.3. Insulin Delivery for Diabetes
6.4. Pediatric Injections
6.5. Other Applications

7. Global Needle Free Drug Delivery Devices Market by Region 2019-2025
7.1. North America
7.1.1. North America Needle Free Drug Delivery Devices Market by Technology
7.1.2. North America Needle Free Drug Delivery Devices Market by Application
7.1.3. North America Needle Free Drug Delivery Devices Market by Country
7.2. Europe
7.2.1. Europe Needle Free Drug Delivery Devices Market by Technology
7.2.2. Europe Needle Free Drug Delivery Devices Market by Application
7.2.3. Europe Needle Free Drug Delivery Devices Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Needle Free Drug Delivery Devices Market by Technology
7.3.2. Asia-Pacific Needle Free Drug Delivery Devices Market by Application
7.3.3. Asia-Pacific Needle Free Drug Delivery Devices Market by Country
7.4. RoW
7.4.1. RoW Needle Free Drug Delivery Devices Market by Technology
7.4.2. RoW Needle Free Drug Delivery Devices Market by Application
7.4.3. RoW Needle Free Drug Delivery Devices Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Needle Free Drug Delivery Devices Market
8.2. Companies Profiles
8.2.1. 3 M
8.2.2. AkraDermojetInc
8.2.3. Antares Pharma Inc.
8.2.4. Bayer Ag
8.2.5. Bioject Medical Technologies, Inc.
8.2.6. GlaxosmithklinPlc
8.2.7. Glide Pharmaceutical Technologies Ltd.
8.2.8. InjexPharma Ag
8.2.9. Medtronic, Inc.
8.2.10. Zogenix, Inc.
8.2.11. Other Companies.

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3
  • 3 M
  • AkraDermojetInc
  • Antares Pharma Inc.
  • Bayer Ag
  • Bioject Medical Technologies, Inc.
  • GlaxosmithklinPlc
  • Glide Pharmaceutical Technologies Ltd.
  • InjexPharma Ag
  • Medtronic, Inc.
  • Zogenix, Inc.
  • Other companies.
Note: Product cover images may vary from those shown
Adroll
adroll